List of Tables
Table 1. Global Benign Prostatic Hyperplasia Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tamsulosin
Table 3. Key Players of Finasteride
Table 4. Key Players of Terazosin
Table 5. Key Players of Other
Table 6. Global Benign Prostatic Hyperplasia Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Benign Prostatic Hyperplasia Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Benign Prostatic Hyperplasia Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Benign Prostatic Hyperplasia Drugs Market Share by Region (2020-2025)
Table 10. Global Benign Prostatic Hyperplasia Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Benign Prostatic Hyperplasia Drugs Market Share by Region (2026-2031)
Table 12. Benign Prostatic Hyperplasia Drugs Market Trends
Table 13. Benign Prostatic Hyperplasia Drugs Market Drivers
Table 14. Benign Prostatic Hyperplasia Drugs Market Challenges
Table 15. Benign Prostatic Hyperplasia Drugs Market Restraints
Table 16. Global Benign Prostatic Hyperplasia Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Benign Prostatic Hyperplasia Drugs Market Share by Players (2020-2025)
Table 18. Global Top Benign Prostatic Hyperplasia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia Drugs as of 2024)
Table 19. Ranking of Global Top Benign Prostatic Hyperplasia Drugs Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Benign Prostatic Hyperplasia Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Benign Prostatic Hyperplasia Drugs, Headquarters and Area Served
Table 22. Global Key Players of Benign Prostatic Hyperplasia Drugs, Product and Application
Table 23. Global Key Players of Benign Prostatic Hyperplasia Drugs, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Benign Prostatic Hyperplasia Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Benign Prostatic Hyperplasia Drugs Revenue Market Share by Type (2020-2025)
Table 27. Global Benign Prostatic Hyperplasia Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Benign Prostatic Hyperplasia Drugs Revenue Market Share by Type (2026-2031)
Table 29. Global Benign Prostatic Hyperplasia Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Benign Prostatic Hyperplasia Drugs Revenue Market Share by Application (2020-2025)
Table 31. Global Benign Prostatic Hyperplasia Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Benign Prostatic Hyperplasia Drugs Revenue Market Share by Application (2026-2031)
Table 33. North America Benign Prostatic Hyperplasia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Benign Prostatic Hyperplasia Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Benign Prostatic Hyperplasia Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Benign Prostatic Hyperplasia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Benign Prostatic Hyperplasia Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Benign Prostatic Hyperplasia Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Benign Prostatic Hyperplasia Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Benign Prostatic Hyperplasia Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Benign Prostatic Hyperplasia Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Benign Prostatic Hyperplasia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Benign Prostatic Hyperplasia Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Benign Prostatic Hyperplasia Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Benign Prostatic Hyperplasia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Benign Prostatic Hyperplasia Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Benign Prostatic Hyperplasia Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 48. Sanofi Company Details
Table 49. Sanofi Business Overview
Table 50. Sanofi Benign Prostatic Hyperplasia Drugs Product
Table 51. Sanofi Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 52. Sanofi Recent Development
Table 53. Boehringer Ingelheim Company Details
Table 54. Boehringer Ingelheim Business Overview
Table 55. Boehringer Ingelheim Benign Prostatic Hyperplasia Drugs Product
Table 56. Boehringer Ingelheim Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 57. Boehringer Ingelheim Recent Development
Table 58. Maithili Life Sciences Company Details
Table 59. Maithili Life Sciences Business Overview
Table 60. Maithili Life Sciences Benign Prostatic Hyperplasia Drugs Product
Table 61. Maithili Life Sciences Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 62. Maithili Life Sciences Recent Development
Table 63. DM Pharma Company Details
Table 64. DM Pharma Business Overview
Table 65. DM Pharma Benign Prostatic Hyperplasia Drugs Product
Table 66. DM Pharma Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 67. DM Pharma Recent Development
Table 68. Teva Pharmaceuticals Company Details
Table 69. Teva Pharmaceuticals Business Overview
Table 70. Teva Pharmaceuticals Benign Prostatic Hyperplasia Drugs Product
Table 71. Teva Pharmaceuticals Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 72. Teva Pharmaceuticals Recent Development
Table 73. Mylan Company Details
Table 74. Mylan Business Overview
Table 75. Mylan Benign Prostatic Hyperplasia Drugs Product
Table 76. Mylan Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 77. Mylan Recent Development
Table 78. Zydus Pharmaceuticals Company Details
Table 79. Zydus Pharmaceuticals Business Overview
Table 80. Zydus Pharmaceuticals Benign Prostatic Hyperplasia Drugs Product
Table 81. Zydus Pharmaceuticals Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 82. Zydus Pharmaceuticals Recent Development
Table 83. Wockhardt Company Details
Table 84. Wockhardt Business Overview
Table 85. Wockhardt Benign Prostatic Hyperplasia Drugs Product
Table 86. Wockhardt Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 87. Wockhardt Recent Development
Table 88. Sun Pharmaceutical Company Details
Table 89. Sun Pharmaceutical Business Overview
Table 90. Sun Pharmaceutical Benign Prostatic Hyperplasia Drugs Product
Table 91. Sun Pharmaceutical Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 92. Sun Pharmaceutical Recent Development
Table 93. Glenmark Pharmaceuticals Ltd. Company Details
Table 94. Glenmark Pharmaceuticals Ltd. Business Overview
Table 95. Glenmark Pharmaceuticals Ltd. Benign Prostatic Hyperplasia Drugs Product
Table 96. Glenmark Pharmaceuticals Ltd. Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 97. Glenmark Pharmaceuticals Ltd. Recent Development
Table 98. TRB Pharma S.A. Company Details
Table 99. TRB Pharma S.A. Business Overview
Table 100. TRB Pharma S.A. Benign Prostatic Hyperplasia Drugs Product
Table 101. TRB Pharma S.A. Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 102. TRB Pharma S.A. Recent Development
Table 103. Kunming Jida Pharmaceutical Co., Ltd. Company Details
Table 104. Kunming Jida Pharmaceutical Co., Ltd. Business Overview
Table 105. Kunming Jida Pharmaceutical Co., Ltd. Benign Prostatic Hyperplasia Drugs Product
Table 106. Kunming Jida Pharmaceutical Co., Ltd. Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 107. Kunming Jida Pharmaceutical Co., Ltd. Recent Development
Table 108. Medzeel Lifescience Company Details
Table 109. Medzeel Lifescience Business Overview
Table 110. Medzeel Lifescience Benign Prostatic Hyperplasia Drugs Product
Table 111. Medzeel Lifescience Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 112. Medzeel Lifescience Recent Development
Table 113. Wellona Pharma Company Details
Table 114. Wellona Pharma Business Overview
Table 115. Wellona Pharma Benign Prostatic Hyperplasia Drugs Product
Table 116. Wellona Pharma Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 117. Wellona Pharma Recent Development
Table 118. Niksan Pharmaceutical Company Details
Table 119. Niksan Pharmaceutical Business Overview
Table 120. Niksan Pharmaceutical Benign Prostatic Hyperplasia Drugs Product
Table 121. Niksan Pharmaceutical Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 122. Niksan Pharmaceutical Recent Development
Table 123. Lunan Pharmaceutical Group Corporation Company Details
Table 124. Lunan Pharmaceutical Group Corporation Business Overview
Table 125. Lunan Pharmaceutical Group Corporation Benign Prostatic Hyperplasia Drugs Product
Table 126. Lunan Pharmaceutical Group Corporation Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 127. Lunan Pharmaceutical Group Corporation Recent Development
Table 128. Zhejiang Xianju Pharmaceutical Co.,Ltd. Company Details
Table 129. Zhejiang Xianju Pharmaceutical Co.,Ltd. Business Overview
Table 130. Zhejiang Xianju Pharmaceutical Co.,Ltd. Benign Prostatic Hyperplasia Drugs Product
Table 131. Zhejiang Xianju Pharmaceutical Co.,Ltd. Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 132. Zhejiang Xianju Pharmaceutical Co.,Ltd. Recent Development
Table 133. Hunan Jiudian Pharmaceutical Co.,Ltd. Company Details
Table 134. Hunan Jiudian Pharmaceutical Co.,Ltd. Business Overview
Table 135. Hunan Jiudian Pharmaceutical Co.,Ltd. Benign Prostatic Hyperplasia Drugs Product
Table 136. Hunan Jiudian Pharmaceutical Co.,Ltd. Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 137. Hunan Jiudian Pharmaceutical Co.,Ltd. Recent Development
Table 138. Chengdu Brilliant Pharmaceutical Co., Ltd. Company Details
Table 139. Chengdu Brilliant Pharmaceutical Co., Ltd. Business Overview
Table 140. Chengdu Brilliant Pharmaceutical Co., Ltd. Benign Prostatic Hyperplasia Drugs Product
Table 141. Chengdu Brilliant Pharmaceutical Co., Ltd. Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 142. Chengdu Brilliant Pharmaceutical Co., Ltd. Recent Development
Table 143. Guangdong Eashu Pharmaceutical Co.,Ltd. Company Details
Table 144. Guangdong Eashu Pharmaceutical Co.,Ltd. Business Overview
Table 145. Guangdong Eashu Pharmaceutical Co.,Ltd. Benign Prostatic Hyperplasia Drugs Product
Table 146. Guangdong Eashu Pharmaceutical Co.,Ltd. Revenue in Benign Prostatic Hyperplasia Drugs Business (2020-2025) & (US$ Million)
Table 147. Guangdong Eashu Pharmaceutical Co.,Ltd. Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Benign Prostatic Hyperplasia Drugs Picture
Figure 2. Global Benign Prostatic Hyperplasia Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Benign Prostatic Hyperplasia Drugs Market Share by Type: 2024 VS 2031
Figure 4. Tamsulosin Features
Figure 5. Finasteride Features
Figure 6. Terazosin Features
Figure 7. Other Features
Figure 8. Global Benign Prostatic Hyperplasia Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Benign Prostatic Hyperplasia Drugs Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Other Case Studies
Figure 13. Benign Prostatic Hyperplasia Drugs Report Years Considered
Figure 14. Global Benign Prostatic Hyperplasia Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Benign Prostatic Hyperplasia Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Benign Prostatic Hyperplasia Drugs Market Share by Region: 2024 VS 2031
Figure 17. Global Benign Prostatic Hyperplasia Drugs Market Share by Players in 2024
Figure 18. Global Top Benign Prostatic Hyperplasia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia Drugs as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Benign Prostatic Hyperplasia Drugs Revenue in 2024
Figure 20. North America Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Benign Prostatic Hyperplasia Drugs Market Share by Country (2020-2031)
Figure 22. United States Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Benign Prostatic Hyperplasia Drugs Market Share by Country (2020-2031)
Figure 26. Germany Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Benign Prostatic Hyperplasia Drugs Market Share by Region (2020-2031)
Figure 34. China Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Benign Prostatic Hyperplasia Drugs Market Share by Country (2020-2031)
Figure 42. Mexico Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Benign Prostatic Hyperplasia Drugs Market Share by Country (2020-2031)
Figure 46. Turkey Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Benign Prostatic Hyperplasia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Sanofi Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 51. Maithili Life Sciences Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 52. DM Pharma Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 53. Teva Pharmaceuticals Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 54. Mylan Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 55. Zydus Pharmaceuticals Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 56. Wockhardt Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 57. Sun Pharmaceutical Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 58. Glenmark Pharmaceuticals Ltd. Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 59. TRB Pharma S.A. Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 60. Kunming Jida Pharmaceutical Co., Ltd. Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 61. Medzeel Lifescience Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 62. Wellona Pharma Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 63. Niksan Pharmaceutical Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 64. Lunan Pharmaceutical Group Corporation Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 65. Zhejiang Xianju Pharmaceutical Co.,Ltd. Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 66. Hunan Jiudian Pharmaceutical Co.,Ltd. Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 67. Chengdu Brilliant Pharmaceutical Co., Ltd. Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 68. Guangdong Eashu Pharmaceutical Co.,Ltd. Revenue Growth Rate in Benign Prostatic Hyperplasia Drugs Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
